A limitation of this study is that the exact molecular events leading to the hyper-responsiveness of the non-canonical inflammasome remain elusive, and clinical data are currently insufficient to assess whether patients suffering from SPG11 or SPG48 are prone to infection-related complications. This evidence concerns the gene AP5Z1 and infection.